Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, TianYu Bio-Technology Co's Enterprise Value is ¥2,847.1 Mil.
TianYu Bio-Technology Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ¥122.8 Mil. Therefore, TianYu Bio-Technology Co's EV-to-FCF for today is 23.18.
The historical rank and industry rank for TianYu Bio-Technology Co's EV-to-FCF or its related term are showing as below:
SHSE:603717'
s EV-to-FCF Range Over the Past 10 Years
Min: -590.63 Med: -11.94 Max: 787.55
Current: 23.18
During the past 13 years, the highest EV-to-FCF of TianYu Bio-Technology Co was 787.55. The lowest was -590.63. And the median was -11.94.
SHSE:603717's EV-to-FCF is ranked worse than 66.58% of 1101
companies
in the Construction industry
Industry Median: 13.32
vs SHSE:603717: 23.18
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
TianYu Bio-Technology Co (SHSE:603717) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
TianYu Bio-Technology Co's PE Ratio (TTM) for today is calculated as:
TianYu Bio-Technology Co's share price for today is ¥6.01.
TianYu Bio-Technology Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0.452.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
TianYu Bio-Technology Co EV-to-FCF Related Terms
TianYu Bio-Technology Co EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:603717 vs PWR, FIX, EME: EV-to-FCF Comparison
For the Engineering & Construction subindustry, TianYu Bio-Technology Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TianYu Bio-Technology Co EV-to-FCF vs Construction Industry
For the Construction industry and Industrials sector, TianYu Bio-Technology Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where TianYu Bio-Technology Co's EV-to-FCF falls into.
TianYu Bio-Technology Co's current Enterprise Value is ¥2,847.1 Mil.
TianYu Bio-Technology Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥122.8 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TianYu Bio-Technology Co (SHSE:603717) has a EV-to-FCF of 23.18 as of Aug. 09, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on TianYu Bio-Technology Co and its competitors. According to the industry distribution chart, TianYu Bio-Technology Co ranks #733 out of 1101 companies in the Construction industry, placing it in the top 66.6%.
Is TianYu Bio-Technology Co's EV-to-FCF too high?
TianYu Bio-Technology Co's current EV-to-FCF is 23.18. The Construction industry median EV-to-FCF is 13.32. TianYu Bio-Technology Co's value of 23.18 is 74% above this industry median. Based on the distribution chart, TianYu Bio-Technology Co ranks #733 out of 1101 companies in the Construction industry, which is below the industry midpoint. Overall, TianYu Bio-Technology Co has a GF Score™ of 54/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does TianYu Bio-Technology Co's EV-to-FCF compare to PWR and FIX?
According to the Construction industry distribution chart, TianYu Bio-Technology Co ranks #733 out of 1101 companies for EV-to-FCF. This places TianYu Bio-Technology Co in the lower half of its industry. The industry median EV-to-FCF is 13.32. TianYu Bio-Technology Co's value of 23.18 is 74% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Construction company?
The median EV-to-FCF among Construction companies is 13.32, based on 1,101 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TianYu Bio-Technology Co's current EV-to-FCF of 23.18 is 74% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on TianYu Bio-Technology Co and its competitors. For the Construction industry, the median EV-to-FCF is 13.32 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TianYu Bio-Technology Co's current EV-to-FCF is 23.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TianYu Bio-Technology Co stock overvalued right now?
Based on GuruFocus' analysis, TianYu Bio-Technology Co (SHSE:603717) is currently considered Fairly Valued. The stock's GF Value™ is ¥5.72, compared to a current price of ¥6.01 — trading 5.1% above its estimated fair value. The current EV-to-FCF is 23.18 and 74% above the Construction industry median of 13.32. TianYu Bio-Technology Co's overall GF Score™ is 54/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For TianYu Bio-Technology Co (SHSE:603717), the current EV-to-FCF is 23.18 as of Aug. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is TianYu Bio-Technology Co (SHSE:603717) Overvalued in 2026?
Based on GuruFocus' analysis, TianYu Bio-Technology Co stock appears to be overvalued.
The current stock price of ¥6.01 is trading 5.1% above its estimated GF Value™ of ¥5.72.
GuruFocus considers TianYu Bio-Technology Co to be Fairly Valued.
Key valuation signals for SHSE:603717:
EV-to-FCF: 23.18
GF Value™: ¥5.72 vs. price of ¥6.01 (5.1% above fair value)
Industry Position: 74% above the Construction median (#733 of 1101)
No single metric tells the full story. See the SHSE:603717 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
TianYu Bio-Technology Co Ltd is engaged in Garden ecological engineering business, ecological environment management and rural complex business, pig breeding business, production and marketing of agricultural products and cash crops.
54GF Score
Get the complete analysis for SHSE:603717
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:603717 has been successfully added to your 
